Dentsply Sirona Inc Faces Securities Fraud Class Action Lawsuit
| XRAY Stock | USD 19.63 0.01 0.05% |
Slightly above 62% of Dentsply Sirona's investor base is looking to short. The analysis of overall sentiment of trading Dentsply Sirona stock suggests that many investors are alarmed at this time. Dentsply Sirona's investing sentiment can be driven by a variety of factors including economic data, Dentsply Sirona's earnings reports, geopolitical events, and overall market trends.
Dentsply |
Dentsply Sirona Inc is currently embroiled in a securities fraud class action lawsuit, as announced by Bernstein Liebhard LLP on December 23, 2024. The l
Read at gurufocus.com
 |
Dentsply Sirona Fundamental Analysis
We analyze Dentsply Sirona's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dentsply Sirona using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dentsply Sirona based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Cash And Equivalents
Cash And Equivalents Comparative Analysis
Dentsply Sirona is currently under evaluation in cash and equivalents category among its peers. Cash or Cash Equivalents are the most liquid of all assets found on the company's balance sheet. It is used in calculating many of the firm's liquidity ratios and is a good indicator of the overall financial health of a company. Companies with a lot of cash are usually attractive takeover targets. Cash Equivalents are balance sheet items that are typically reported using currency printed on notes.
Dentsply Sirona Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dentsply Sirona stock to make a market-neutral strategy. Peer analysis of Dentsply Sirona could also be used in its relative valuation, which is a method of valuing Dentsply Sirona by comparing valuation metrics with similar companies.
Peers
Dentsply Sirona Related Equities
| RMD | ResMed | 1.89 | ||||
| HAE | Haemonetics | 1.73 | ||||
| WST | West Pharmaceutical | 1.28 | ||||
| HOLX | Hologic | 1.06 | ||||
| TFX | Teleflex Incorporated | 1.04 | ||||
| ALC | Alcon AG | 1.03 | ||||
| BDX | Becton Dickinson | 0.64 | ||||
| COO | Cooper Companies, | 0.10 | ||||
| MMSI | Merit Medical | 0.30 | ||||
| ANGO | AngioDynamics | 0.40 | ||||
| ICUI | ICU Medical | 1.42 |
Additional Tools for Dentsply Stock Analysis
When running Dentsply Sirona's price analysis, check to measure Dentsply Sirona's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dentsply Sirona is operating at the current time. Most of Dentsply Sirona's value examination focuses on studying past and present price action to predict the probability of Dentsply Sirona's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dentsply Sirona's price. Additionally, you may evaluate how the addition of Dentsply Sirona to your portfolios can decrease your overall portfolio volatility.